Agilent Technologies, Inc. (A) Sets New 1-Year High at $62.73
Agilent Technologies, Inc. (NYSE:A)’s share price hit a new 52-week high during trading on Tuesday . The company traded as high as $62.73 and last traded at $62.74, with a volume of 605,943 shares traded. The stock had previously closed at $61.74.
A has been the subject of a number of research analyst reports. Barclays PLC reaffirmed a “buy” rating and issued a $67.00 price target on shares of Agilent Technologies in a report on Wednesday, July 19th. Deutsche Bank AG reaffirmed a “buy” rating and issued a $66.00 price target on shares of Agilent Technologies in a report on Thursday, June 22nd. BidaskClub downgraded Agilent Technologies from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 13th. BTIG Research upped their price target on Agilent Technologies from $57.00 to $65.00 and gave the company a “buy” rating in a report on Wednesday, May 24th. Finally, Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $63.00 price target for the company in a report on Tuesday, May 16th. Three research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $63.18.
The stock has a market capitalization of $20.21 billion, a P/E ratio of 32.37 and a beta of 1.30. The firm’s 50 day moving average price is $60.55 and its 200 day moving average price is $56.47.
Agilent Technologies (NYSE:A) last posted its earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.07. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The business had revenue of $1.11 billion for the quarter, compared to analysts’ expectations of $1.09 billion. During the same period in the prior year, the company posted $0.49 EPS. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. On average, equities analysts expect that Agilent Technologies, Inc. will post $2.32 EPS for the current year.
In other Agilent Technologies news, insider Mark Doak sold 21,851 shares of the stock in a transaction that occurred on Tuesday, May 30th. The shares were sold at an average price of $60.00, for a total value of $1,311,060.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Didier Hirsch sold 72,545 shares of the stock in a transaction that occurred on Tuesday, August 22nd. The stock was sold at an average price of $62.38, for a total transaction of $4,525,357.10. The disclosure for this sale can be found here. Insiders sold a total of 141,233 shares of company stock worth $8,698,716 over the last quarter.
Hedge funds have recently bought and sold shares of the company. Whittier Trust Co. boosted its stake in Agilent Technologies by 1.3% in the first quarter. Whittier Trust Co. now owns 14,401 shares of the medical research company’s stock valued at $762,000 after buying an additional 182 shares during the period. AMF Pensionsforsakring AB bought a new stake in Agilent Technologies during the first quarter valued at $17,911,000. Shell Asset Management Co. boosted its stake in Agilent Technologies by 20.4% in the first quarter. Shell Asset Management Co. now owns 60,747 shares of the medical research company’s stock valued at $3,212,000 after buying an additional 10,299 shares during the period. Glen Harbor Capital Management LLC boosted its stake in Agilent Technologies by 6.7% in the first quarter. Glen Harbor Capital Management LLC now owns 15,232 shares of the medical research company’s stock valued at $805,000 after buying an additional 952 shares during the period. Finally, Acadian Asset Management LLC boosted its stake in Agilent Technologies by 4,588.8% in the first quarter. Acadian Asset Management LLC now owns 83,414 shares of the medical research company’s stock valued at $4,410,000 after buying an additional 81,635 shares during the period.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.